Phase II Trial of Erlotinib Monotherapy for Pretreated Elderly Patients with Advanced EGFR Wild-Type Non-Small-Cell Lung Cancer

被引：0
|
作者：
Minemura, Hiroyuki [1 ]
Yokouchi, Hiroshi [1 ]
Azuma, Keisuke [1 ]
Hirai, Kenichiro [1 ]
Sekine, Satoko [1 ]
Oshima, Kengo [1 ]
Kanazawa, Kenya [1 ]
Tanino, Yoshinori [1 ]
Inokoshi, Yayoi [2 ]
Ishii, Taeko [2 ]
Katsuura, Yutaka [2 ]
Oishi, Akio [3 ]
Ishida, Takashi [1 ]
Munakata, Mitsuru [1 ]
机构：
[1] Fukushima Med Univ, Dept Pulm Med, Fukushima, Japan
[2] Saiseikai Fukushima Gen Hosp, Dept Pulm Med, Fukushima, Japan
[3] Fukushima Red Cross Hosp, Dept Thorac Surg, Fukushima, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
elderly; Non-small-cell lung cancer; Erlotinib; EGFR wild-type;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-074
引用
收藏
页码：S547 / S547
页数：1
相关论文
共 50 条
  • [41] A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non-Small-Cell Lung Cancer
    Swaminath, Anand
    Wright, James R.
    Tsakiridis, Theodoros K.
    Ung, Yee C.
    Pond, Gregory R.
    Sur, Ranjan
    Corbett, Thomas B.
    Okawara, Gordon
    Leyine, Mark N.
    [J]. CLINICAL LUNG CANCER, 2016, 17 (02) : 142 - 149
  • [42] EGFR tyrosine kinase inhibitor in advanced non-small cell lung cancer with wild-type EGFR
    Wang, Z.
    Wu, Y. L.
    Yang, J.
    Wang, B.
    Huang, Y.
    Zhou, Q.
    Xu, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 1202
    Kuyama, Shoichi
    Ochi, Nobuaki
    Bessho, Akihiro
    Hotta, Katsuyuki
    Ikeda, Genyo
    Kishino, Daizo
    Kubo, Toshio
    Harada, Daijiro
    Fujimoto, Nobukazu
    Nakanishi, Masamoto
    Umeno, Takahiro
    Okada, Toshiaki
    Chikamori, Kenichi
    Yamagishi, Tomoko
    Ohashi, Kadoaki
    Ichihara, Eiki
    Takigawa, Nagio
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    [J]. LUNG CANCER, 2017, 112 : 188 - 194
  • [44] Phase II pharmacodynamic trial of erlotinib in previously treated patients with advanced non-small-cell lung cancer (NSCLC):: Study results
    Felip, Enriqueta
    Rojo, Frederico
    Reck, Martin
    Heller, Astrid
    Klughammer, Barbara
    Maacke, Heiko
    Mocks, Joachim
    Brennscheidt, Ulrich
    Gatzemeier, Ulrich
    Baselga, Jose
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 235 - 235
  • [45] Erlotinib in combination with bevacizumab for patients with recurrent non-small-cell lung cancer: a phase I/II trial
    Herbst, Roy S.
    Johnson, David
    Blumenschein, George
    Henderson, Ted
    Liu, Diane
    Truong, Mylene
    Ramies, David
    Mass, Robert
    Garcia, Ben
    Sandler, Alan B.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 170 - 170
  • [46] Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2
    Lilenbaum, Rogerio
    Axelrod, Rita
    Thomas, Sachdev
    Dowlati, Afshin
    Seigel, Leonard
    Albert, Donald
    Witt, Karsten
    Botkin, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) : 863 - 869
  • [47] Docetaxel as monotherapy in the treatment of advanced non-small-cell lung cancer in elderly patients - Reply
    Kudoh, Shinzoh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (09) : 1144 - 1144
  • [48] Efficacy and Safety of Capmatinib Plus Nivolumab in Pretreated Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
    Felip, E.
    Minotti, V.
    Tan, D.
    Wolf, J.
    Mark, M.
    Boyer, M.
    Hughes, B.
    Bearz, A.
    Moro-Sibilot, D.
    Le, X.
    Vazquez, J.
    Massuti, B.
    Liu, N.
    Hao, L.
    Cheng, Y.
    Tiedt, R.
    Cobo, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S585 - S586
  • [49] A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small cell lung cancer with wild-type EGFR: The Okayama Lung Cancer Study Group Trial 1202 (OLCSG1202)
    Bessho, A.
    Ochi, N.
    Kuyama, S.
    Umeno, T.
    Ikeda, G.
    Harada, D.
    Nogami, N.
    Ninomiya, K.
    Kishino, D.
    Chikamori, K.
    Fujimoto, N.
    Hotta, K.
    Takigawa, N.
    Kiura, K.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [50] The efficacy of erlotinib for patients with non-small cell lung cancer with wild type of EGFR mutations
    Kobayashi, Takashi
    Koizumi, Tomonobu
    Tanabe, Tsuyoshi
    Tsushima, Kenji
    Urushihata, Kazuhisa
    Yamamoto, Hiroshi
    Hanaoka, Masayuki
    Kubo, Keishi
    Koyama, Shigeru
    Ooura, Nariaki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S690 - S690
12345